Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability
Open Access
- 18 April 2016
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 84 (3), 567-584
- https://doi.org/10.3390/scipharm84030567
Abstract
Traditional tinctures of Cannabis sativa L. became obsolete before elucidation of the main cannabinoids and routine quality testing for medicines. In view of increasing medicinal use of cannabinoids and associated safety concerns, tinctures from a Δ9-tetrahydrocannabinol (THC)-type chemovar were studied. High-performance liquid chromatography with diode-array detection (HPLC/DAD) was used to determine THC, Δ9-tetrahydrocannabinolic acid A (THCA), cannabinol (CBN), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabigerol (CBG), cannabigerolic acid (CBGA), cannflavin A/B, and total phenolics. Derived group and ratio markers describe absolute and relative profiles when varying plant part (flos, folium), extraction solvent (EtOH percentage), storage conditions (‘shelf’ or ‘fridge’ up to 15 months), and pasteurization (2 h 70 °C, 20 min 80 °C). Tinctures from female flowering tops contained ten-fold more cannabinoids than tinctures from leaves; tinctures (80%–90% EtOH) contained ten-fold more cannabinoids than tinctures (40% EtOH). The analysis of CBGA + CBG, the main co-cannabinoids aside from THCA + THC, appears more relevant than CBDA + CBD. The decarboxylation of THCA to THC—the main change during storage of freshly prepared tinctures—is after 15 months in the ‘fridge’ comparable to 3 months on the ‘shelf’. Minimally increased CBN totals did not correlate to diminished totals of THCA and THC (up to 15% after 3 months ‘shelf’, 45% after 15 months ‘fridge’). Instead, total cannabinoids or acidic/neutral cannabinoid ratios are better stability markers. Moderate changes after pasteurization and partial losses below 10% for total cannabinoids after 9 months ‘fridge’ indicate possibilities for a reasonable shelf life. Yet storage and use of non-stabilized tinctures remain critical without authorized specification and stability data because a consistent cannabinoid content is not guaranteed.Keywords
This publication has 30 references indexed in Scilit:
- 1 H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specificationTalanta, 2015
- Cannabis and Its Derivatives: Review of Medical UseThe Journal of the American Board of Family Medicine, 2011
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ9-Tetrahydrocannabinol and Oromucosal Cannabis Extract AdministrationClinical Chemistry, 2011
- Standardized natural product cannabis in pain management and observations at a Canadian compassion society: a case reportCases Journal, 2009
- Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on Δ9-THC and Δ9-THC-acidPhytochemistry, 2008
- Chromatographic and Spectroscopic Data of Cannabinoids fromCannabis sativaL.Journal of Liquid Chromatography & Related Technologies, 2005
- A Single Centre, Placebo-Controlled, Four Period, Crossover, Tolerability Study Assessing, Pharmacodynamic Effects, Pharmacokinetic Characteristics and Cognitive Profiles of a Single Dose of Three Formulations of Cannabis Based Medicine Extracts (CBMEs) (GWPD9901), Plus a Two Period Tolerability Study Comparing Pharmacodynamic Effects and Pharmacokinetic Characteristics of a Single Dose of a Cannabis Based Medicine Extract Given via Two Administration Routes (GWPD9901 EXT)Journal of Cannabis Therapeutics, 2004
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Hemp for HeadacheJournal of Cannabis Therapeutics, 2001
- Simple high-performance liquid chromatographic method for separating acidic and neutral cannabinoids in cannabis sativa L.Journal of Chromatography A, 1982